Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 32 entries
Sorted by: Best Match Show Resources per page
Advances in Molecular Serotyping and Subtyping of Escherichia coli.

Frontiers in microbiology

Fratamico PM, DebRoy C, Liu Y, Needleman DS, Baranzoni GM, Feng P.
PMID: 27199968
Front Microbiol. 2016 May 03;7:644. doi: 10.3389/fmicb.2016.00644. eCollection 2016.

Escherichia coli plays an important role as a member of the gut microbiota; however, pathogenic strains also exist, including various diarrheagenic E. coli pathotypes and extraintestinal pathogenic E. coli that cause illness outside of the GI-tract. E. coli have...

Cite
Fratamico PM, DebRoy C, Liu Y, et al. Advances in Molecular Serotyping and Subtyping of Escherichia coli. Front Microbiol. 2016;7:644doi: 10.3389/fmicb.2016.00644.
Fratamico, P. M., DebRoy, C., Liu, Y., Needleman, D. S., Baranzoni, G. M., & Feng, P. (2016). Advances in Molecular Serotyping and Subtyping of Escherichia coli. Frontiers in microbiology, 7644. https://doi.org/10.3389/fmicb.2016.00644
Fratamico, Pina M, et al. "Advances in Molecular Serotyping and Subtyping of Escherichia coli." Frontiers in microbiology vol. 7 (2016): 644. doi: https://doi.org/10.3389/fmicb.2016.00644
Fratamico PM, DebRoy C, Liu Y, Needleman DS, Baranzoni GM, Feng P. Advances in Molecular Serotyping and Subtyping of Escherichia coli. Front Microbiol. 2016 May 03;7:644. doi: 10.3389/fmicb.2016.00644. eCollection 2016. PMID: 27199968; PMCID: PMC4853403.
Copy Download .nbib Format: NLM
Outer Membrane Proteins and Lipopolysaccharides in Pathovars of Xanthomonas campestris.

Applied and environmental microbiology

Ojanen T, Helander IM, Haahtela K, Korhonen TK, Laakso T.
PMID: 16349114
Appl Environ Microbiol. 1993 Dec;59(12):4143-51. doi: 10.1128/aem.59.12.4143-4151.1993.

Variations in the outer membrane proteins (OMPs) and lipopolysaccharides (LPSs) of 54 isolates belonging to 16 different pathovars of Xanthomonas campestris were characterized. OMP samples prepared by sarcosyl extraction of cell walls and LPS samples prepared by proteinase K...

Cite
Ojanen T, Helander IM, Haahtela K, et al. Outer Membrane Proteins and Lipopolysaccharides in Pathovars of Xanthomonas campestris. Appl Environ Microbiol. 1993;59(12):4143-51doi: 10.1128/aem.59.12.4143-4151.1993.
Ojanen, T., Helander, I. M., Haahtela, K., Korhonen, T. K., & Laakso, T. (1993). Outer Membrane Proteins and Lipopolysaccharides in Pathovars of Xanthomonas campestris. Applied and environmental microbiology, 59(12), 4143-51. https://doi.org/10.1128/aem.59.12.4143-4151.1993
Ojanen, T, et al. "Outer Membrane Proteins and Lipopolysaccharides in Pathovars of Xanthomonas campestris." Applied and environmental microbiology vol. 59,12 (1993): 4143-51. doi: https://doi.org/10.1128/aem.59.12.4143-4151.1993
Ojanen T, Helander IM, Haahtela K, Korhonen TK, Laakso T. Outer Membrane Proteins and Lipopolysaccharides in Pathovars of Xanthomonas campestris. Appl Environ Microbiol. 1993 Dec;59(12):4143-51. doi: 10.1128/aem.59.12.4143-4151.1993. PMID: 16349114; PMCID: PMC195878.
Copy Download .nbib Format: NLM
Distribution of serotypes and antibiotic resistance of invasive Pseudomonas aeruginosa in a multi-country collection.

BMC microbiology

Nasrin S, Hegerle N, Sen S, Nkeze J, Sen S, Permala-Booth J, Choi M, Sinclair J, Tapia MD, Johnson JK, Sow SO, Thaden JT, Fowler VG, Krogfelt KA, Brauner A, Protonotariou E, Christaki E, Shindo Y, Kwa AL, Shakoor S, Singh-Moodley A, Perovic O, Jacobs J, Lunguya O, Simon R, Cross AS, Tennant SM.
PMID: 34991476
BMC Microbiol. 2022 Jan 06;22(1):13. doi: 10.1186/s12866-021-02427-4.

BACKGROUND: Pseudomonas aeruginosa is an opportunistic pathogen that causes a wide range of acute and chronic infections and is frequently associated with healthcare-associated infections. Because of its ability to rapidly acquire resistance to antibiotics, P. aeruginosa infections are difficult...

Cite
Nasrin S, Hegerle N, Sen S, et al. Distribution of serotypes and antibiotic resistance of invasive Pseudomonas aeruginosa in a multi-country collection. BMC Microbiol. 2022;22(1):13doi: 10.1186/s12866-021-02427-4.
Nasrin, S., Hegerle, N., Sen, S., Nkeze, J., Sen, S., Permala-Booth, J., Choi, M., Sinclair, J., Tapia, M. D., Johnson, J. K., Sow, S. O., Thaden, J. T., Fowler, V. G., Krogfelt, K. A., Brauner, A., Protonotariou, E., Christaki, E., Shindo, Y., Kwa, A. L., Shakoor, S., Singh-Moodley, A., Perovic, O., Jacobs, J., Lunguya, O., Simon, R., Cross, A. S., & Tennant, S. M. (2022). Distribution of serotypes and antibiotic resistance of invasive Pseudomonas aeruginosa in a multi-country collection. BMC microbiology, 22(1), 13. https://doi.org/10.1186/s12866-021-02427-4
Nasrin, Shamima, et al. "Distribution of serotypes and antibiotic resistance of invasive Pseudomonas aeruginosa in a multi-country collection." BMC microbiology vol. 22,1 (2022): 13. doi: https://doi.org/10.1186/s12866-021-02427-4
Nasrin S, Hegerle N, Sen S, Nkeze J, Sen S, Permala-Booth J, Choi M, Sinclair J, Tapia MD, Johnson JK, Sow SO, Thaden JT, Fowler VG, Krogfelt KA, Brauner A, Protonotariou E, Christaki E, Shindo Y, Kwa AL, Shakoor S, Singh-Moodley A, Perovic O, Jacobs J, Lunguya O, Simon R, Cross AS, Tennant SM. Distribution of serotypes and antibiotic resistance of invasive Pseudomonas aeruginosa in a multi-country collection. BMC Microbiol. 2022 Jan 06;22(1):13. doi: 10.1186/s12866-021-02427-4. PMID: 34991476.
Copy Download .nbib Format: NLM
Targeting of Pseudomonas aeruginosa cell surface via GP12, an Escherichia coli specific bacteriophage protein.

Scientific reports

Ongwae GM, Chordia MD, Cawley JL, Dalesandro BE, Wittenberg NJ, Pires MM.
PMID: 35031652
Sci Rep. 2022 Jan 14;12(1):721. doi: 10.1038/s41598-021-04627-4.

Bacteriophages are highly abundant molecular machines that have evolved proteins to target the surface of host bacterial cells. Given the ubiquity of lipopolysaccharides (LPS) on the outer membrane of Gram-negative bacteria, we reasoned that targeting proteins from bacteriophages could...

Cite
Ongwae GM, Chordia MD, Cawley JL, et al. Targeting of Pseudomonas aeruginosa cell surface via GP12, an Escherichia coli specific bacteriophage protein. Sci Rep. 2022;12(1):721doi: 10.1038/s41598-021-04627-4.
Ongwae, G. M., Chordia, M. D., Cawley, J. L., Dalesandro, B. E., Wittenberg, N. J., & Pires, M. M. (2022). Targeting of Pseudomonas aeruginosa cell surface via GP12, an Escherichia coli specific bacteriophage protein. Scientific reports, 12(1), 721. https://doi.org/10.1038/s41598-021-04627-4
Ongwae, George M, et al. "Targeting of Pseudomonas aeruginosa cell surface via GP12, an Escherichia coli specific bacteriophage protein." Scientific reports vol. 12,1 (2022): 721. doi: https://doi.org/10.1038/s41598-021-04627-4
Ongwae GM, Chordia MD, Cawley JL, Dalesandro BE, Wittenberg NJ, Pires MM. Targeting of Pseudomonas aeruginosa cell surface via GP12, an Escherichia coli specific bacteriophage protein. Sci Rep. 2022 Jan 14;12(1):721. doi: 10.1038/s41598-021-04627-4. PMID: 35031652.
Copy Download .nbib Format: NLM
Hemolysin-Producing Strains among Diarrheagenic .

Pathogens (Basel, Switzerland)

Mare A, Man A, Toma F, Ciurea CN, Coșeriu RL, Vintilă C, Maier AC.
PMID: 33291609
Pathogens. 2020 Dec 04;9(12). doi: 10.3390/pathogens9121022.

Even if serotyping based on O antigens is still routinely used by most laboratories for the detection of diarrheagenic

Cite
Mare A, Man A, Toma F, et al. Hemolysin-Producing Strains among Diarrheagenic . Pathogens. 2020;9(12)doi: 10.3390/pathogens9121022.
Mare, A., Man, A., Toma, F., Ciurea, C. N., Coșeriu, R. L., Vintilă, C., & Maier, A. C. (2020). Hemolysin-Producing Strains among Diarrheagenic . Pathogens (Basel, Switzerland), 9(12), . https://doi.org/10.3390/pathogens9121022
Mare, Anca, et al. "Hemolysin-Producing Strains among Diarrheagenic ." Pathogens (Basel, Switzerland) vol. 9,12 (2020). doi: https://doi.org/10.3390/pathogens9121022
Mare A, Man A, Toma F, Ciurea CN, Coșeriu RL, Vintilă C, Maier AC. Hemolysin-Producing Strains among Diarrheagenic . Pathogens. 2020 Dec 04;9(12). doi: 10.3390/pathogens9121022. PMID: 33291609; PMCID: PMC7761922.
Copy Download .nbib Format: NLM
The Q Proteins and Non-Specific O-Antigens of the Cholera Vibrio.

The Journal of hygiene

White PB.
PMID: 20475298
J Hyg (Lond). 1935 Dec;35(4):498-503. doi: 10.1017/s0022172400032514.

No abstract available.

Cite
White PB. The Q Proteins and Non-Specific O-Antigens of the Cholera Vibrio. J Hyg (Lond). 1935;35(4):498-503doi: 10.1017/s0022172400032514.
White, P. B. (1935). The Q Proteins and Non-Specific O-Antigens of the Cholera Vibrio. The Journal of hygiene, 35(4), 498-503. https://doi.org/10.1017/s0022172400032514
White, P B. "The Q Proteins and Non-Specific O-Antigens of the Cholera Vibrio." The Journal of hygiene vol. 35,4 (1935): 498-503. doi: https://doi.org/10.1017/s0022172400032514
White PB. The Q Proteins and Non-Specific O-Antigens of the Cholera Vibrio. J Hyg (Lond). 1935 Dec;35(4):498-503. doi: 10.1017/s0022172400032514. PMID: 20475298; PMCID: PMC2170936.
Copy Download .nbib Format: NLM
Molecular serogrouping of .

Animal health research reviews

DebRoy C, Fratamico PM, Roberts E.
PMID: 29467055
Anim Health Res Rev. 2018 Jun;19(1):1-16. doi: 10.1017/S1466252317000093. Epub 2018 Feb 22.

O-antigens present on the surface of Escherichia coli provide antigenic specificity for the strain and are the main components for O-serogroup designation. Serotyping using O-group-specific antisera for the identification of E. coli O-serogroups has been traditionally the gold-standard for...

Cite
DebRoy C, Fratamico PM, Roberts E. Molecular serogrouping of . Anim Health Res Rev. 2018;19(1):1-16doi: 10.1017/S1466252317000093.
DebRoy, C., Fratamico, P. M., & Roberts, E. (2018). Molecular serogrouping of . Animal health research reviews, 19(1), 1-16. https://doi.org/10.1017/S1466252317000093
DebRoy, Chitrita, et al. "Molecular serogrouping of ." Animal health research reviews vol. 19,1 (2018): 1-16. doi: https://doi.org/10.1017/S1466252317000093
DebRoy C, Fratamico PM, Roberts E. Molecular serogrouping of . Anim Health Res Rev. 2018 Jun;19(1):1-16. doi: 10.1017/S1466252317000093. Epub 2018 Feb 22. PMID: 29467055.
Copy Download .nbib Format: NLM
Ten Years of Population-Level Genomic Escherichia coli and Klebsiella pneumoniae Serotype Surveillance Informs Vaccine Development for Invasive Infections.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America

Lipworth S, Vihta KD, Chau KK, Kavanagh J, Davies T, George S, Barker L, Vaughan A, Andersson M, Jeffery K, Oakley S, Morgan M, Peto TEA, Crook DW, Walker AS, Stoesser N.
PMID: 33411882
Clin Infect Dis. 2021 Dec 16;73(12):2276-2282. doi: 10.1093/cid/ciab006.

BACKGROUND: The incidence of bloodstream infections (BSIs) caused by Escherichia coli and Klebsiella pneumoniae is increasing, with substantial associated morbidity, mortality, and antimicrobial resistance. Unbiased serotyping studies to guide vaccine target selection are limited.METHODS: We conducted unselected, population-level genomic...

Cite
Lipworth S, Vihta KD, Chau KK, et al. Ten Years of Population-Level Genomic Escherichia coli and Klebsiella pneumoniae Serotype Surveillance Informs Vaccine Development for Invasive Infections. Clin Infect Dis. 2021;73(12):2276-2282doi: 10.1093/cid/ciab006.
Lipworth, S., Vihta, K. D., Chau, K. K., Kavanagh, J., Davies, T., George, S., Barker, L., Vaughan, A., Andersson, M., Jeffery, K., Oakley, S., Morgan, M., Peto, T. E. A., Crook, D. W., Walker, A. S., & Stoesser, N. (2021). Ten Years of Population-Level Genomic Escherichia coli and Klebsiella pneumoniae Serotype Surveillance Informs Vaccine Development for Invasive Infections. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 73(12), 2276-2282. https://doi.org/10.1093/cid/ciab006
Lipworth, Samuel, et al. "Ten Years of Population-Level Genomic Escherichia coli and Klebsiella pneumoniae Serotype Surveillance Informs Vaccine Development for Invasive Infections." Clinical infectious diseases : an official publication of the Infectious Diseases Society of America vol. 73,12 (2021): 2276-2282. doi: https://doi.org/10.1093/cid/ciab006
Lipworth S, Vihta KD, Chau KK, Kavanagh J, Davies T, George S, Barker L, Vaughan A, Andersson M, Jeffery K, Oakley S, Morgan M, Peto TEA, Crook DW, Walker AS, Stoesser N. Ten Years of Population-Level Genomic Escherichia coli and Klebsiella pneumoniae Serotype Surveillance Informs Vaccine Development for Invasive Infections. Clin Infect Dis. 2021 Dec 16;73(12):2276-2282. doi: 10.1093/cid/ciab006. PMID: 33411882; PMCID: PMC8677521.
Copy Download .nbib Format: NLM
Ten Years of Population-Level Genomic Escherichia coli and Klebsiella pneumoniae Serotype Surveillance Informs Vaccine Development for Invasive Infections.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America

Lipworth S, Vihta KD, Chau KK, Kavanagh J, Davies T, George S, Barker L, Vaughan A, Andersson M, Jeffery K, Oakley S, Morgan M, Peto TEA, Crook DW, Walker AS, Stoesser N.
PMID: 33411882
Clin Infect Dis. 2021 Dec 16;73(12):2276-2282. doi: 10.1093/cid/ciab006.

BACKGROUND: The incidence of bloodstream infections (BSIs) caused by Escherichia coli and Klebsiella pneumoniae is increasing, with substantial associated morbidity, mortality, and antimicrobial resistance. Unbiased serotyping studies to guide vaccine target selection are limited.METHODS: We conducted unselected, population-level genomic...

Cite
Lipworth S, Vihta KD, Chau KK, et al. Ten Years of Population-Level Genomic Escherichia coli and Klebsiella pneumoniae Serotype Surveillance Informs Vaccine Development for Invasive Infections. Clin Infect Dis. 2021;73(12):2276-2282doi: 10.1093/cid/ciab006.
Lipworth, S., Vihta, K. D., Chau, K. K., Kavanagh, J., Davies, T., George, S., Barker, L., Vaughan, A., Andersson, M., Jeffery, K., Oakley, S., Morgan, M., Peto, T. E. A., Crook, D. W., Walker, A. S., & Stoesser, N. (2021). Ten Years of Population-Level Genomic Escherichia coli and Klebsiella pneumoniae Serotype Surveillance Informs Vaccine Development for Invasive Infections. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 73(12), 2276-2282. https://doi.org/10.1093/cid/ciab006
Lipworth, Samuel, et al. "Ten Years of Population-Level Genomic Escherichia coli and Klebsiella pneumoniae Serotype Surveillance Informs Vaccine Development for Invasive Infections." Clinical infectious diseases : an official publication of the Infectious Diseases Society of America vol. 73,12 (2021): 2276-2282. doi: https://doi.org/10.1093/cid/ciab006
Lipworth S, Vihta KD, Chau KK, Kavanagh J, Davies T, George S, Barker L, Vaughan A, Andersson M, Jeffery K, Oakley S, Morgan M, Peto TEA, Crook DW, Walker AS, Stoesser N. Ten Years of Population-Level Genomic Escherichia coli and Klebsiella pneumoniae Serotype Surveillance Informs Vaccine Development for Invasive Infections. Clin Infect Dis. 2021 Dec 16;73(12):2276-2282. doi: 10.1093/cid/ciab006. PMID: 33411882; PMCID: PMC8677521.
Copy Download .nbib Format: NLM
Targeting of Pseudomonas aeruginosa cell surface via GP12, an Escherichia coli specific bacteriophage protein.

Scientific reports

Ongwae GM, Chordia MD, Cawley JL, Dalesandro BE, Wittenberg NJ, Pires MM.
PMID: 35031652
Sci Rep. 2022 Jan 14;12(1):721. doi: 10.1038/s41598-021-04627-4.

Bacteriophages are highly abundant molecular machines that have evolved proteins to target the surface of host bacterial cells. Given the ubiquity of lipopolysaccharides (LPS) on the outer membrane of Gram-negative bacteria, we reasoned that targeting proteins from bacteriophages could...

Cite
Ongwae GM, Chordia MD, Cawley JL, et al. Targeting of Pseudomonas aeruginosa cell surface via GP12, an Escherichia coli specific bacteriophage protein. Sci Rep. 2022;12(1):721doi: 10.1038/s41598-021-04627-4.
Ongwae, G. M., Chordia, M. D., Cawley, J. L., Dalesandro, B. E., Wittenberg, N. J., & Pires, M. M. (2022). Targeting of Pseudomonas aeruginosa cell surface via GP12, an Escherichia coli specific bacteriophage protein. Scientific reports, 12(1), 721. https://doi.org/10.1038/s41598-021-04627-4
Ongwae, George M, et al. "Targeting of Pseudomonas aeruginosa cell surface via GP12, an Escherichia coli specific bacteriophage protein." Scientific reports vol. 12,1 (2022): 721. doi: https://doi.org/10.1038/s41598-021-04627-4
Ongwae GM, Chordia MD, Cawley JL, Dalesandro BE, Wittenberg NJ, Pires MM. Targeting of Pseudomonas aeruginosa cell surface via GP12, an Escherichia coli specific bacteriophage protein. Sci Rep. 2022 Jan 14;12(1):721. doi: 10.1038/s41598-021-04627-4. PMID: 35031652.
Copy Download .nbib Format: NLM
Rapid Genomic Characterization and Global Surveillance of Klebsiella Using Pathogenwatch.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America

Argimón S, David S, Underwood A, Abrudan M, Wheeler NE, Kekre M, Abudahab K, Yeats CA, Goater R, Taylor B, Harste H, Muddyman D, Feil EJ, Brisse S, Holt K, Donado-Godoy P, Ravikumar KL, Okeke IN, Carlos C, Aanensen DM.
PMID: 34850838
Clin Infect Dis. 2021 Dec 01;73:S325-S335. doi: 10.1093/cid/ciab784.

BACKGROUND: Klebsiella species, including the notable pathogen K. pneumoniae, are increasingly associated with antimicrobial resistance (AMR). Genome-based surveillance can inform interventions aimed at controlling AMR. However, its widespread implementation requires tools to streamline bioinformatic analyses and public health reporting.METHODS:...

Cite
Argimón S, David S, Underwood A, et al. Rapid Genomic Characterization and Global Surveillance of Klebsiella Using Pathogenwatch. Clin Infect Dis. 2021;73:S325-S335doi: 10.1093/cid/ciab784.
Argimón, S., David, S., Underwood, A., Abrudan, M., Wheeler, N. E., Kekre, M., Abudahab, K., Yeats, C. A., Goater, R., Taylor, B., Harste, H., Muddyman, D., Feil, E. J., Brisse, S., Holt, K., Donado-Godoy, P., Ravikumar, K. L., Okeke, I. N., Carlos, C., Aanensen, D. M. (2021). Rapid Genomic Characterization and Global Surveillance of Klebsiella Using Pathogenwatch. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 73S325-S335. https://doi.org/10.1093/cid/ciab784
Argimón, Silvia, et al. "Rapid Genomic Characterization and Global Surveillance of Klebsiella Using Pathogenwatch." Clinical infectious diseases : an official publication of the Infectious Diseases Society of America vol. 73 (2021): S325-S335. doi: https://doi.org/10.1093/cid/ciab784
Argimón S, David S, Underwood A, Abrudan M, Wheeler NE, Kekre M, Abudahab K, Yeats CA, Goater R, Taylor B, Harste H, Muddyman D, Feil EJ, Brisse S, Holt K, Donado-Godoy P, Ravikumar KL, Okeke IN, Carlos C, Aanensen DM. Rapid Genomic Characterization and Global Surveillance of Klebsiella Using Pathogenwatch. Clin Infect Dis. 2021 Dec 01;73:S325-S335. doi: 10.1093/cid/ciab784. PMID: 34850838; PMCID: PMC8634497.
Copy Download .nbib Format: NLM
Immunoglobulin GM and KM allotypes are associated with antibody responses to Pseudomonas aeruginosa antigens in chronically infected cystic fibrosis patients.

Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society

Pandey JP, Namboodiri AM, Nietert PJ, Knowles MR, Pace RG, Pier GB.
PMID: 34246573
J Cyst Fibros. 2021 Nov;20(6):1080-1084. doi: 10.1016/j.jcf.2021.06.011. Epub 2021 Jul 07.

BACKGROUND: Chronic infection with Pseudomonas aeruginosa (P. aeruginosa) is a leading cause of death in patients with cystic fibrosis (CF). Immunobiology of P. aeruginosa infection is complex and not well understood. Chronically infected CF patients generate high levels of...

Cite
Pandey JP, Namboodiri AM, Nietert PJ, et al. Immunoglobulin GM and KM allotypes are associated with antibody responses to Pseudomonas aeruginosa antigens in chronically infected cystic fibrosis patients. J Cyst Fibros. 2021;20(6):1080-1084doi: 10.1016/j.jcf.2021.06.011.
Pandey, J. P., Namboodiri, A. M., Nietert, P. J., Knowles, M. R., Pace, R. G., & Pier, G. B. (2021). Immunoglobulin GM and KM allotypes are associated with antibody responses to Pseudomonas aeruginosa antigens in chronically infected cystic fibrosis patients. Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society, 20(6), 1080-1084. https://doi.org/10.1016/j.jcf.2021.06.011
Pandey, Janardan P, et al. "Immunoglobulin GM and KM allotypes are associated with antibody responses to Pseudomonas aeruginosa antigens in chronically infected cystic fibrosis patients." Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society vol. 20,6 (2021): 1080-1084. doi: https://doi.org/10.1016/j.jcf.2021.06.011
Pandey JP, Namboodiri AM, Nietert PJ, Knowles MR, Pace RG, Pier GB. Immunoglobulin GM and KM allotypes are associated with antibody responses to Pseudomonas aeruginosa antigens in chronically infected cystic fibrosis patients. J Cyst Fibros. 2021 Nov;20(6):1080-1084. doi: 10.1016/j.jcf.2021.06.011. Epub 2021 Jul 07. PMID: 34246573.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 32 entries